Friday, September 12, 2025

Latest

Psyched Wellness Raises $6.6 Million In Bought Deal Financing

Psyched Wellness (CSE: PSYC) has closed its previously announced private placement. The company managed to raise an impressive $6.6 million under the financing, a sizeable increase from the initial $3.0 million that was to be raised under the financing.

The offering saw a total of 21.3 million units of the company sold at a price of $0.31 per unit. Each unit consists of one common share and one common share purchase warrant, with each warrant valid for a period of three years from the date of issuance with an exercise price of $0.43 per share.

Warrants issued under the offering are also subject to an acceleration clause, whereby the company can accelerate the expiry if the equity trades above $0.70 for a period of five days on a volume weighted basis.

Proceeds from the offering are to be used to fully fund the pre-clinical trials of the firms proprietary amanita muscaria extract, known as AME-1, as well as to continue researching the compound and its potential for people suffering from mental and physical health issues. Proceeds are also to be used for general corporate purposes.

Psyched Wellness last traded at $0.55 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Daily Dive: Shroom Stocks About To Fly? With Jeff Stevens, CEO Of Psyched Wellness

Today on The Daily Dive we have Jeff Stevens, CEO of Psyched Wellness (CSE: PSYC)....

Monday, November 9, 2020, 01:00:00 PM

Psyched Wellness Announces Study On Muscimol Antioxidant and Anti-Inflammatory Properties

Psyched Wellness (CSE: PSYC) has begun yet another study related to that of the Amanita...

Wednesday, January 6, 2021, 07:48:08 AM

Psyched Wellness Launches Study On Mushroom Extract Focused On Gut Health

Psyched Wellness (CSE: PSYC) this morning issued a very brief press release related to ongoing...

Tuesday, March 30, 2021, 08:31:58 AM

Psyched Wellness Sees Positive Results From Amanita Muscaria Toxicology Report

Psyched Wellness (CSE: PSYC) has completed its toxicology assessment on that of Amanita Muscaria, the...

Monday, December 7, 2020, 07:56:50 AM

Psyched Wellness To Conduct Stability Tests On Proprietary Mushroom Extract

Psyched Wellness (CSE: PSYC) is progressing with the development of its flagship product, an extract...

Monday, July 26, 2021, 09:28:00 AM